Soc. Generale Knock-Out SK/ DE000SQ4ZQT4 /
9/17/2024 8:26:08 AM | Chg.+0.35 | Bid12:09:05 PM | Ask12:09:05 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
16.42EUR | +2.18% | 16.96 Bid Size: 200 |
17.15 Ask Size: 200 |
SEB SA | 77.3277 EUR | 12/31/2078 | Call |
GlobeNewswire
7/17
SocialFi Platform RECRD Emerges From Stealth With $4M Funding Led by Sui Foundation & Alphabit Fund;...
GlobeNewswire
6/25
PEAK:AIO Commits to the Future of AI Healthcare; Announces the Appointment of Professor Sebastien Ou...
GlobeNewswire
1/29
Journal of the American Academy of Dermatology Publishes ZORYVE (roflumilast) Foam, 0.3% Results for...
GlobeNewswire
1/22
ZORYVE® (roflumilast) Topical Foam, 0.3%, for the Treatment of Seborrheic Dermatitis Launches in the...
GlobeNewswire
9/25/2023
New Campaign from Arcutis Aims to Educate, Raise Awareness, and Provide Encouragement for Those Livi...
Newsfile Corp
10/10/2022
GaiaLens Unveils its ESG Reporting Capability as Part of its Data-Driven, AI-Based ESG Analytics Pla...
GlobeNewswire
1/27/2022
F2 Strategy’s 2022 Outlook Report Shows Cryptocurrency Adoption, Data Aggregation and Operations Aut...
GlobeNewswire
12/22/2021
MicroEJ and Groupe SEB, leader in small domestic appliances, announce their collaboration in the dev...
GlobeNewswire
11/3/2021
Bestselling 'Beauty of Horror' Creator Alan Robert Launches Whitelist for 'Monster Chompers' NFT Col...
GlobeNewswire
9/16/2021
F2 Strategy Trailblazes WealthTech Space with Record Growth of Outsourced CTO and Consulting Service...
GlobeNewswire
7/12/2021
Arcutis Announces First Patient Enrolled in Phase 3 Clinical Trial of Topical Roflumilast Foam (ARQ-...
GlobeNewswire
5/25/2021
Sinch AB (publ): Sinch completes a directed new share issue of 7,232,077 shares, raising approximate...
GlobeNewswire
5/24/2021
Sinch AB (publ): Sinch evaluates the conditions to carry out a directed new share issue